ACRO BIOMEDICAL CO., LTD. Quarterly Revenues in USD from Q4 2017 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Acro Biomedical Co., Ltd. quarterly/annual Revenues history and growth rate from Q4 2017 to Q2 2023.
  • Acro Biomedical Co., Ltd. Revenues for the quarter ending June 30, 2023 was $0.000.
  • Acro Biomedical Co., Ltd. annual Revenues for 2022 was $659K, a 45% decline from 2021.
  • Acro Biomedical Co., Ltd. annual Revenues for 2021 was $1.2M.
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $0 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $0 -$299K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2023-08-02
Q2 2022 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $299K +$199K +200% Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-02
Q1 2021 $99.5K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2018 $1.96M Jan 1, 2018 Mar 31, 2018 10-Q 2018-08-01
Q4 2017 $1.45M Oct 1, 2017 Dec 31, 2017 10-Q 2018-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.